Rank #272
Zhu Yi
Net worth $11.6B
Pharmaceuticals · China
- Born
- Dec 01, 1963
- Age
- 62
- Source
- Pharmaceuticals
- Residence
- Chengdu, Sichuan
- Citizenship
- China
- Marital status
- Children
- 0
- Education
Net worth over time
Biography
- Zhu Yi is the chairman of Biokin Pharmaceutical, a developer of drugs including anesthesia injections, cancer drugs as well as traditional Chinese medicine treatments.
- The company went public in Shanghai in 2023, raising $136 million; it has been seeking a Hong Kong IPO since 2024.
- Biokin's U.S. subsidiary SystImmune signed in 2023 an $8.4 billion deal with Bristol Myers Squibb to jointly develop and commercialize a potential cancer treatment worldwide.
- Zhu taught immunology and microbiology at West China University of Medical Sciences before striking out on his own.
- Zhu has a master's in biology from Fudan University and a doctorate in management from Sichuan University.
Financial assets
| Exchange | Ticker | Shares | Price |
|---|